About Endonovo Therapeutics
Endonovo Therapeutics is a company based in Los Angeles (United States) founded in 2011.. Endonovo Therapeutics offers products and services including SofPulse® Electroceutical® Therapy and Electroceuticals®. Endonovo Therapeutics operates in a competitive market with competitors including Blackrock Neurotech, MindMaze, Nexstim, Precision Neuroscience and Synergia Medical, among others.
- Headquarter Los Angeles, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Endonovo Therapeutics, Inc.
-
Annual Revenue
$10.04 K-92.84as on Dec 31, 2024
-
Net Profit
$-2.8 M-140.4as on Dec 31, 2024
-
EBITDA
$-941.4 K58.57as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Cavalry Fund
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Endonovo Therapeutics
Endonovo Therapeutics is a publicly listed company on the OTC with ticker symbol ENDV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Endonovo Therapeutics
Endonovo Therapeutics offers a comprehensive portfolio of products and services, including SofPulse® Electroceutical® Therapy and Electroceuticals®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive device for palliative pain and swelling treatment.
Wearable system for promoting wound healing and anti-inflammatory effects.
Unlock access to complete
Unlock access to complete
Funding Insights of Endonovo Therapeutics
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(11 Aug 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Post-IPO - Endonovo Therapeutics | Valuation |
investors |
|
| Nov, 2019 | Amount | Post-IPO - Endonovo Therapeutics | Valuation |
investors |
|
| Jul, 2016 | Amount | Post-IPO - Endonovo Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endonovo Therapeutics
Endonovo Therapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Cavalry Fund and Bellridge Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Cavalry Fund's operations.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endonovo Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endonovo Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endonovo Therapeutics Comparisons
Competitors of Endonovo Therapeutics
Endonovo Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blackrock Neurotech, MindMaze, Nexstim, Precision Neuroscience and Synergia Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for neurological therapies are developed.
|
|
| domain | founded_year | HQ Location |
Evidence-based digital neurotherapeutics are developed for brain health recovery.
|
|
| domain | founded_year | HQ Location |
Noninvasive brain stimulation is provided for stroke patient rehabilitation.
|
|
| domain | founded_year | HQ Location |
Brain-computer interfaces developed for medical treatment and drug development.
|
|
| domain | founded_year | HQ Location |
Implantable neurostimulators and contactless monitoring systems are developed.
|
|
| domain | founded_year | HQ Location |
Developer of bioabsorbable synthetic heart valves and vascular grafts
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Endonovo Therapeutics
Frequently Asked Questions about Endonovo Therapeutics
When was Endonovo Therapeutics founded?
Endonovo Therapeutics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Endonovo Therapeutics located?
Endonovo Therapeutics is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
What is the annual revenue of Endonovo Therapeutics?
Annual revenue of Endonovo Therapeutics is $10.04K as on Dec 31, 2024.
What does Endonovo Therapeutics do?
Endonovo Therapeutics was founded in 2011 and is headquartered in Los Angeles, United States. Operations focus on the biotechnology sector, where non-invasive bioelectronic devices are provided to address vital organ failure by reducing inflammation and promoting cell regeneration. A Cytotronics platform is utilized for cell expansion and manipulation through simulated microgravity and time-varying electromagnetic fields, supporting tissue engineering and cell therapies.
Who are the top competitors of Endonovo Therapeutics?
Endonovo Therapeutics's top competitors include Blackrock Neurotech, Precision Neuroscience and Nexstim.
What products or services does Endonovo Therapeutics offer?
Endonovo Therapeutics offers SofPulse® Electroceutical® Therapy and Electroceuticals®.
Is Endonovo Therapeutics publicly traded?
Yes, Endonovo Therapeutics is publicly traded on OTC under the ticker symbol ENDV.
Who are Endonovo Therapeutics's investors?
Endonovo Therapeutics has 2 investors. Key investors include Cavalry Fund, and Bellridge Capital.
What is Endonovo Therapeutics's ticker symbol?
The ticker symbol of Endonovo Therapeutics is ENDV on OTC.